These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25740578)

  • 1. Changes of naturally occurring CD4(+)CD25(+) FOXP3(+) regulatory T cells in patients with acute coronary syndrome and the beneficial effects of atorvastatin treatment.
    Wang ZX; Wang CQ; Li XY; Ding Y; Feng GK; Jiang XJ
    Int Heart J; 2015; 56(2):163-9. PubMed ID: 25740578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of CD4+CD25+ regulatory T cells in patients with acute coronary syndrome and the effects of atorvastatin.
    Hu Z; Li D; Hu Y; Yang K
    J Huazhong Univ Sci Technolog Med Sci; 2007 Oct; 27(5):524-7. PubMed ID: 18060626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome.
    Lü CX; Xu RD; Cao M; Wang G; Yan FQ; Shang SS; Wu XF; Ruan L; Quan XQ; Zhang CT
    Atherosclerosis; 2013 Jul; 229(1):263-70. PubMed ID: 23735638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes of Foxp3(+); regulatory T cells in patients with acute coronary syndrome].
    Zhao Z; Qi YZ; Yuan ZY; Cheng ML; Ji YQ; Yang XB
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Aug; 27(8):893-5. PubMed ID: 21806889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heme oxygenase-1 restores impaired GARPCD4⁺CD25⁺ regulatory T cells from patients with acute coronary syndrome by upregulating LAP and GARP expression on activated T lymphocytes.
    Liu Y; Zhao X; Zhong Y; Meng K; Yu K; Shi H; Wu B; Tony H; Zhu J; Zhu R; Peng Y; Mao Y; Cheng P; Mao X; Zeng Q
    Cell Physiol Biochem; 2015; 35(2):553-70. PubMed ID: 25612606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease--a randomized, placebo-controlled study.
    Alber HF; Frick M; Suessenbacher A; Doerler J; Schirmer M; Stocker EM; Dichtl W; Pachinger O; Weidinger F
    Am Heart J; 2006 Jan; 151(1):139. PubMed ID: 16368305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells.
    Hendrikx TK; van Gurp EA; Mol WM; Schoordijk W; Sewgobind VD; Ijzermans JN; Weimar W; Baan CC
    Nephrol Dial Transplant; 2009 Jun; 24(6):1969-78. PubMed ID: 19193737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of coinhibitory PD-L1 on CD4⁺CD25⁺FOXP3⁺ regulatory T cells is elevated in patients with acute coronary syndrome.
    Li SH; Chen WJ; Yan M; Shu YW; Liao YH
    Coron Artery Dis; 2015 Nov; 26(7):598-603. PubMed ID: 26166019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: a longitudinal study during atorvastatin treatment.
    Guasti L; Maresca AM; Schembri L; Rasini E; Dentali F; Squizzato A; Klersy C; Robustelli Test L; Mongiardi C; Campiotti L; Ageno W; Grandi AM; Cosentino M; Marino F
    BMC Cardiovasc Disord; 2016 Jan; 16():26. PubMed ID: 26822994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-10 and TGF-beta immunoregulatory cytokines rather than natural regulatory T cells are associated with the resolution phase of Vogt-Koyanagi-Harada (VKH) syndrome.
    Commodaro AG; Peron JP; Genre J; Arslanian C; Sanches L; Muccioli C; Rizzo LV; Belfort R
    Scand J Immunol; 2010 Jul; 72(1):31-7. PubMed ID: 20591073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
    Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
    Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matured human monocyte-derived dendritic cells (MoDCs) induce expansion of CD4+CD25+FOXP3+ T cells lacking regulatory properties.
    Merlo A; Tagliabue E; Mènard S; Balsari A
    Immunol Lett; 2008 Apr; 117(1):106-13. PubMed ID: 18295349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of alanyl-aminopeptidase on CD4+CD25+ regulatory T-cells enhances expression of FoxP3 and TGF-beta1 and ameliorates acute colitis in mice.
    Bank U; Tadje J; Täger M; Wolke C; Bukowska A; Ittenson A; Reinhold D; Helmuth M; Ansorge S; Shakespeare A; Vieth M; Malfertheiner P; Naumann M; Lendeckel U
    Int J Mol Med; 2007 Oct; 20(4):483-92. PubMed ID: 17786278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foxp3 regulates human natural CD4+CD25+ regulatory T-cell-mediated suppression of xenogeneic response.
    Sun L; Yi S; O'Connell PJ
    Xenotransplantation; 2010; 17(2):121-30. PubMed ID: 20522244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells.
    Mausner-Fainberg K; Luboshits G; Mor A; Maysel-Auslender S; Rubinstein A; Keren G; George J
    Atherosclerosis; 2008 Apr; 197(2):829-39. PubMed ID: 17826781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis.
    Xu G; Mou Z; Jiang H; Cheng L; Shi J; Xu R; Oh Y; Li H
    Laryngoscope; 2007 May; 117(5):876-80. PubMed ID: 17473687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral atorvastatin on CD4+CD25+ regulatory T cells, FoxP3 expression, and prognosis in patients with ST-segment elevated myocardial infarction before primary percutaneous coronary intervention.
    Zhang D; Wang S; Guan Y; Wang L; Xie W; Li N; Zhao P; Su G
    J Cardiovasc Pharmacol; 2011 May; 57(5):536-41. PubMed ID: 21297491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intensive atorvastatin therapy on periprocedural PDCD4 expression in CD4+ T lymphocytes of patients with unstable angina undergoing percutaneous coronary intervention.
    Su Q; Li L; Liu Y; Zhou Y; Wang J; Sun Y
    Cardiology; 2014; 127(3):169-75. PubMed ID: 24434439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.